At the genomic level, our Mendelian randomization findings revealed WDR6 as a reproducible genetic risk factor for CD, UC, and MDD, highlighting its potential role in shared susceptibility pathways underlying gut–brain axis disorders. Here, WDR6 is linked to major depressive disorder.